ELMDA 10mg Tablet (Dapagliflozin) is a clinically validated SGLT2 inhibitor used in the treatment of type 2 diabetes mellitus. For pharmacies, healthcare providers, and medicine stores, sourcing high-quality antidiabetic medications is critical to ensure patient safety and treatment efficacy. As a leading ELMDA manufacturer in India and ELMDA provider in India, Wych Elm Laboratories Limited offers a consistent, reliable supply for institutional and retail buyers.
Why Pharmacies & Healthcare Providers Choose ELMDA
1. Clinically Proven Composition
ELMDA 10mg Tablet contains:
- Dapagliflozin 10mg – a selective SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, promoting urinary glucose excretion.
This mechanism not only lowers blood sugar levels effectively but also contributes to:
- Weight reduction
- Blood pressure control
- Cardiovascular protection
This combination of benefits makes ELMDA ideal for inclusion in hospital formularies, pharmacy inventories, and chronic care programs.
2. Institutional Advantages
For medicine dealers, pharmacies, and healthcare facilities, ELMDA provides:
- High-quality supply from a trusted manufacturer in India
- Bulk procurement options for clinics and hospitals
- Compliance with GMP and WHO manufacturing standards
- Evidence-based therapeutic efficacy aligned with ADA and IDF guidelines
Wych Elm Laboratories ensures reliable delivery and consistent batch quality, minimizing supply chain issues for institutional buyers.
Uses of ELMDA 10mg Tablet
ELMDA is indicated for:
1. Type 2 Diabetes Mellitus
- Improves blood sugar control in combination with diet, exercise, and other antidiabetic medications.
- Reduces the risk of microvascular complications, including diabetic nephropathy and neuropathy.
2. Cardiovascular Health
- Reduces hospitalization for heart failure in adults with type 2 diabetes and existing heart disease.
- Supports heart health, lowering the risk of cardiovascular events in high-risk populations.
3. Chronic Kidney Disease (CKD)
- Slows progression of kidney disease in patients with type 2 diabetes.
- Reduces the risk of kidney failure, cardiovascular death, and hospitalizations for heart failure.
How ELMDA 10mg Tablet Works
ELMDA Tablet (Dapagliflozin) acts by:
- Blocking SGLT2 in the renal tubules, preventing glucose reabsorption.
- Increasing urinary glucose excretion, which lowers blood sugar independently of insulin.
- Providing additional cardiovascular and renal benefits, including reduced heart failure hospitalization and improved kidney outcomes.
This insulin-independent mechanism makes ELMDA suitable for combination therapy with metformin, sulfonylureas, or insulin, offering flexibility in treatment protocols.
Dosage & Administration
- Dose: As prescribed by the doctor, usually 10mg once daily.
- Route: Oral, with or without food.
- Timing: Preferably at the same time each day.
Important for pharmacists and clinics: Ensure patients are educated about hydration, potential urinary side effects, and monitoring blood glucose regularly.
Safety Profile & Side Effects
Common Side Effects:
- Nausea
- Polyuria (frequent urination)
- Genital fungal infections
- Urinary tract infections
- Nasopharyngitis (throat and nasal inflammation)
Precautions for Special Populations:
- Pregnancy & Lactation: Consult a doctor before use.
- Kidney Disease: Dose adjustment may be required; monitor renal function.
- Liver Disease: Safe if prescribed; severe liver dysfunction requires caution.
- Alcohol: Avoid as it may increase risk of side effects.
Pharmacy Tip: Advise patients to maintain hydration and practice genital hygiene to minimize side effects.
Benefits of ELMDA 10mg Tablet
- Effective Glycemic Control: Lowers HbA1c and fasting blood glucose levels.
- Cardiovascular Protection: Reduces hospitalization for heart failure and cardiovascular death risk.
- Renal Protection: Slows progression of CKD and reduces proteinuria.
- Weight Management: Promotes modest weight loss in type 2 diabetes patients.
- Flexible Therapy: Can be combined with other oral antidiabetic agents or insulin.
Pharmacist Guidance: ELMDA is suitable for institutional formularies, chronic care clinics, and diabetes management programs.
Tips for Medicine Dealers & Clinics
- Educate patients on hydration and UTI prevention.
- Monitor renal function and blood glucose levels.
- Combine therapy with metformin or other antidiabetic medications when clinically indicated.
- Stock sufficient bulk supply to prevent shortages in hospitals and clinics.
FAQs for Pharmacies, Dealers & Healthcare Providers
Q1: What is ELMDA 10mg Tablet used for?
A: ELMDA is an SGLT2 inhibitor used for type 2 diabetes, providing blood sugar control, cardiovascular protection, and renal benefits.
Q2: Can ELMDA 10mg Tablet be combined with metformin?
A: Yes. Evidence shows that combination therapy with metformin enhances glycemic control in patients with insufficient response to monotherapy.
Q3: Who should not take ELMDA 10mg Tablet?
A: Patients with severe kidney dysfunction, dialysis patients, or known allergies to Dapagliflozin.
Q4: Does ELMDA 10mg Tablet cause weight loss?
A: Yes, modest weight loss may occur due to urinary glucose excretion. Patients should monitor for dehydration.
Q5: What precautions should patients follow?
A: Maintain hydration, practice genital hygiene, avoid alcohol, monitor blood glucose, and report persistent UTI symptoms.
Q6: How should pharmacies store ELMDA Tablet?
A: Store at room temperature in a cool, dry place away from sunlight and moisture. Keep out of reach of children.
Q7: Can ELMDA prevent heart failure in diabetic patients?
A: Yes, clinical evidence supports reduced hospitalization for heart failure in type 2 diabetes patients with high cardiovascular risk.
Why Wych Elm Laboratories is the Preferred ELMDA Manufacturer in India
For medicine stores, pharmacies, and healthcare institutions, procuring high-quality antidiabetic medications is critical. Wych Elm Laboratories Limited, as a leading ELMDA manufacturer in India, provides:
- GMP-certified, WHO-aligned production
- Bulk supply options for pharmacies and hospitals
- Evidence-based, clinically approved formulations
- Reliable institutional support for order management and compliance
When searching for a trusted ELMDA provider in India, Wych Elm Laboratories ensures therapeutic consistency, quality assurance, and dependable delivery, making it the ideal partner for healthcare institutions and medicine dealers.